Tanshinone: An inhibitor of proliferation of vascular smooth muscle cells
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference29 articles.
1. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases;Bennett;Science,1997
2. ERKs: a family of protein-serinerthreonine kinases that are activated and tyrosine phosphorylated in response to insulin;Boulton;Cell,1991
3. Identification of MAP kinase domains by redirecting stress signals into growth factor responses;Brunet;Science,1996
4. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty;Chang;Jouranl of Clinical Investigation,1995
5. Cell cycle regulation of p70 kinase and p42/p44 mitogen activated protein kinase in Swiss mouse 3T3 fibroblasts;Edelmann;Journal of Biological Chemistry,1996
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies;Cells;2024-09-01
2. Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway;European Journal of Pharmacology;2019-06
3. MicroRNA-451 inhibits vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via Ywhaz/p38 MAPK pathway;Experimental Cell Research;2019-06
4. A bioinformatics investigation into the pharmacological mechanisms of the effect of Fufang Danshen on pain based on methodologies of network pharmacology;Scientific Reports;2019-04-11
5. Synergistic study of a Danshen (Salvia Miltiorrhizae Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) combination on cell survival in EA.hy926 cells;BMC Complementary and Alternative Medicine;2019-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3